Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines | Chinese Medicine | Full Text
Ulcerative colitis
Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evid | DDDT
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
Ulcerative colitis - The Lancet
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Figure 3 from Drug Insight: aminosalicylates for the treatment of IBD | Semantic Scholar
![5-aminosalicylates [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/slide1.png?w=600&tok=62b6d2 "5-aminosalicylates [TUSOM | Pharmwiki]")
5-aminosalicylates [TUSOM | Pharmwiki]
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor - ScienceDirect
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art - ScienceDirect
Mesalamine - an overview | ScienceDirect Topics
My Gastro Room: Mesalazine delivary system
A mechanism of action of vedolizumab. | Download Scientific Diagram
PHARMACOLOGY OF COMBINED MESALZINE AND RIFAXIMIN THERAPY TO INFLAMMATORY BOWEL DISEASE | PharmaTutor
Some putative molecular mechanisms that underlie the antineoplastic... | Download Scientific Diagram
Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
Pentasa Full Prescribing Information, Dosage & Side Effects | MIMS Thailand
Mesalazine - Wikipedia
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Ulcerative colitis: an update | RCP Journals
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease - Allgayer - 2003 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Carcinogenesis in Ulcerative Colitis | IntechOpen
IJMS | Free Full-Text | Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Mesalazine in the Chemoprevention of Colorectal Cancer
Ulcerative Colitis: Today, Tomorrow, and the Future - European Medical Journal
